Clinical Trial Update: Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of AZD0284 in healthy subjects, with Plaque Psoriasis Vulgaris listed as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis Vulgaris

Drugs mentioned

• AZD0284

Snippet

Sponsor: AstraZeneca | Conditions: Plaque Psoriasis Vulgaris | Phase 1 | Status: COMPLETED